Kaysen George A, Kotanko Peter, Zhu Fansan, Sarkar Shubho R, Heymsfield Steven B, Kuhlmann Martin K, Levin Nathan W
Renal Research Institute, New York, New York, USA.
J Ren Nutr. 2008 Nov;18(6):473-8. doi: 10.1053/j.jrn.2008.08.006.
Adiposity, measured as increased body mass index (BMI), is associated with reduced all-cause and cardiovascular (CV) mortality in hemodialysis (HD) patients, whereas CV risk increases with BMI in the general population. A major limitation of BMI as a measure of adiposity is its failure to distinguish muscle and fat compartments. In addition, the biology of different adipose compartments is not the same. The visceral adipose tissue (VAT) mass is especially biologically active, secreting a variety of cytokines and adipokines. Alternate methods of estimating body composition were found to have a greater association with CV risk factors than BMI in several populations. We measured total adipose tissue, subcutaneous adipose tissue, and VAT in 48 prevalent HD patients, using magnetic resonance imaging.
Based on these measurements, we developed parsimonious multiple-regression models to estimate these adipose compartments using age, sex, BMI, weight, maximum abdominal circumference (MAC), and race. The parsimonious models for VAT included only age, race, and MAC (adjusted r(2) = 0.776, P < .0001), whereas the subcutaneous adipose tissue model included sex, weight, age, and BMI (adjusted r(2) = 0.91, P < .0001) rather than MAC. The total adipose tissue model included BMI, sex, weight, and age (adjusted r(2) = 0.905, P < .0001).
We propose that measurements of MAC, in addition to height and weight, be included in studies relating body composition to outcomes, because this measure provides a better estimate of the metabolically active VAT pool.
以体重指数(BMI)升高衡量的肥胖与血液透析(HD)患者全因死亡率和心血管(CV)死亡率降低相关,而在普通人群中CV风险随BMI升高而增加。BMI作为肥胖衡量指标的一个主要局限是它无法区分肌肉和脂肪成分。此外,不同脂肪成分的生物学特性也不相同。内脏脂肪组织(VAT)尤其具有生物活性,可分泌多种细胞因子和脂肪因子。在几个人群中发现,与BMI相比,替代的身体成分评估方法与CV危险因素的关联更强。我们使用磁共振成像测量了48例HD患者的总脂肪组织、皮下脂肪组织和VAT。
基于这些测量结果,我们建立了简约多元回归模型,使用年龄、性别、BMI、体重、最大腹围(MAC)和种族来估计这些脂肪成分。VAT的简约模型仅包括年龄、种族和MAC(调整后r² = 0.776,P < .0001),而皮下脂肪组织模型包括性别、体重、年龄和BMI(调整后r² = 0.91,P < .0001)而非MAC。总脂肪组织模型包括BMI、性别、体重和年龄(调整后r² = 0.905,P < .0001)。
我们建议在将身体成分与结局相关的研究中,除身高和体重外,纳入MAC测量,因为该测量能更好地估计代谢活跃的VAT池。